Ovariectomy, hormone pellet and telemetric ECG device implantation
Ovariectomy and sham surgeries were performed in prepubertal LQT2 rabbits that were anesthetized with ketamine, xylazine, and buprenorphine (25 mg/kg; 3.75 mg/kg; 0.03 mg/kg IM), intubated and ventilated with isoflurane (0.5-2% in 0.5 O 2 ). 90-day release pellets (Innovative Research of America) containing 17-estradiol (150 mg), dihydrotestosterone (200 mg), progesterone (150 mg), or placebo were implanted subcutaneously. Telemetric ECG devices (F70-EEE, Data Sciences International) were implanted subcutaneously on the rabbits' back, and pairs of electrodes were tunnelled to the right shoulder, left lateral thorax, and both hips as described 8 . Blood samples were obtained at baseline, after 30 and 60 days of hormonetreatment. Serum hormones were extracted using diethyl-ether, and the levels were quantified using ELISA kits (11-DHTHU-E01, 11-PROHU-E01, 20-DR-4399, ALPCO Diagnostics). As described previously 12, 13 , treatment with 90-day release pellets resulted in significantly (10-15 times) higher hormone levels than in sham-operated or ovariectomized females ( Fig. 1 supplement) , reaching estradiol levels similar to women during the follicular phase, progesterone levels comparable to pregnant rabbits (Lau et al., 1984) , and dihydrotestosterone levels similar to sham-operated males. Transthoracic echocardiography was performed after 8 weeks hormone-treatment (parasternal long axis, 7.5 MHz probe) to exclude pro-hypertrophic hormone effects (Table 1 supplement) .
Telemetric ECG monitoring: QT/RR ratio and arrhythmia screening
Analog telemetric ECG signals were acquired by Dataquest ART data acquisition software (DSI) and were analyzed using Ponemah ECG analysis software (DSI) 8, 9 . Pairs of QT/RR intervals were averaged over 5 s every 20 min during a 24-hour monitoring period.
QT/RR ratio was calculated using linear regressions and QT/RR ratio at baseline and after 4
weeks of hormone-treatment were compared. To evaluate sex hormone effects on QT duration irrespective of the heart rate, we applied the following previously established heart rate correction formula . In rabbits that survived, arrhythmias were analyzed in two 2-hour intervals -2-4 hours and 10-12 hours after EPSwhich were defined by the different time points of death in four rabbits. In rabbits that died within the 96 hours period, arrhythmias were analyzed at the 2-4 hours interval as well as during the 2 hours prior to death. Similarly as in clinical LQTS studies 3 , we assessed the incidence of the compound endpoint major life-threatening cardiac events -defined as pVT and SCD -during the 8 weeks of hormone-treatment.
In vivo electrophysiological studies (EPS)
After 8 EPS were performed at a stimulation cycle length (CL) of 300 and 240 ms at twice the threshold. Ventricular effective refractory periods (VERP) in RVapex and septal-base position were assessed by progressively shortening the S2-interval in 10-ms steps after 8-beat S1
trains. VERP-dispersion, defined as difference between VERPbase and apex, was calculated. Complete EPS were performed at baseline and during isoproterenol infusion (0.10 -0.25 µg/min to increase the spontaneous heart rate to 120%).
Optical mapping
Heart preparation and retrograde perfusion were performed as described 8 in n=4-7 rabbits per group one week after EPS. Blebbistatin (5 M) was added to the perfusate to reduce motion artefacts (Fedorov et al., 2007) . We used a dual voltage-calcium camera system (100x100 pixels, Ultima-L, Scimedia, Japan) 16 and fluorescence probes PGH1 for membrane potential (V m ) (generously provided by Dr. Guy Salama, University of Pittsburgh) and rhod-2 for Ca i (Invitrogen). Images were acquired from the anterior surface of the LV and the field of view was set to 1.5 × 1.5 cm 2 with a spatial resolution of 150 × 150 μm 2 . Hearts were stimulated with progressively faster pacing until either loss of 1:1 capture or VF induction occurred. Sampling rate was set to 1000 f/s, and data were analyzed with custombuilt software using Interactive Data Language (ITT Visual Information Solutions) as described in detail 8, 16 . Action potential duration (APD) maps were calculated by averaging 5 consecutive beats at 350 ms stimulation CL. To investigate hormone effects on early afterdepolarisation (EAD) formation, hearts were exposed to an intra-coronary isoproterenol bolus (140 nM) after performing AV-node ablation with an electrocautery to slow the heart rate (similar to observed AV block prior to in vivo pVT). to -40 mV. For I to recording, holding potential was at -80 mV and test potentials were from -20 to +50 mV with steps of 10 mV lasting 400 ms. For I K1 recording, a 2-second ramp from -120 mV to +60 mV was used as stimulation voltage. For I Ca,L recording, holding potential was -50 mV, test potentials were -40 to +40 mV with 10 mV steps lasting 250 ms. I Ca,L was defined as the difference of peak and steady state current at the end of pulse. E-4031 (5 M)
Patch clamp
and chromanol 293B (30 M) were used for isolating I Kr and I Ks, respectively. Tetrodotoxin (20 μM) and CdCl 2 (0.2 mM) were added to block Na + and Ca 2+ currents.
Western Blot
After 2 months of hormone-treatment, hearts were removed, sectioned, and rapidly frozen in liquid nitrogen. Crude membrane preparations of the LV apex were obtained as 
Statistical analysis
For normally distributed values, we used Student's t-test (paired and unpaired). Chisquare test was used for categorical variables. Analysis was performed with Prism 4.03 for Windows (Graphpad). All data are presented as means  SD if not mentioned otherwise, and a p value < 0.05 was considered significant. 
